These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30776320)

  • 1. Effectiveness and Safety of Off-Label Dose-Reduced Direct Oral Anticoagulants in Atrial Fibrillation.
    Arbel R; Sergienko R; Hammerman A; Greenberg-Dotan S; Batat E; Avnery O; Ellis MH
    Am J Med; 2019 Jul; 132(7):847-855.e3. PubMed ID: 30776320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli G; Reiffel J; Singer DE; Peterson ED; Piccini JP;
    J Am Coll Cardiol; 2016 Dec; 68(24):2597-2604. PubMed ID: 27978942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry.
    Murata N; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itoh S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
    Circ J; 2019 Mar; 83(4):727-735. PubMed ID: 30726797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis.
    Zhang XL; Zhang XW; Wang TY; Wang HW; Chen Z; Xu B; Xu W
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007971. PubMed ID: 34932377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study.
    Chen IC; Chang WT; Hsu PC; Yeh YL; Zheng S; Huang YC; Lin CH; Tsai LM; Lin LJ; Liu PY; Liu YW
    Medicine (Baltimore); 2021 Jun; 100(23):e26272. PubMed ID: 34115024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.
    Douros A; Renoux C; Yin H; Filion KB; Suissa S; Azoulay L
    Am J Med; 2019 Feb; 132(2):191-199.e12. PubMed ID: 30691551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
    Admassie E; Chalmers L; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Initiation of Direct Oral Anticoagulants After Onset of Stroke and Short- and Long-Term Outcomes of Patients With Nonvalvular Atrial Fibrillation.
    Mizoguchi T; Tanaka K; Toyoda K; Yoshimura S; Itabashi R; Takagi M; Todo K; Shiozawa M; Yagita Y; Yoshimoto T; Terasaki T; Yamagami H; Takizawa S; Inoue M; Kamiyama K; Ihara M; Okada Y; Kitazono T; Koga M;
    Stroke; 2020 Mar; 51(3):883-891. PubMed ID: 31964290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Doses of Direct Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.
    Deguchi I; Takao M
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):354-359. PubMed ID: 30401611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
    Martinez BK; Sood NA; Bunz TJ; Coleman CI
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation.
    Kato Y; Hayashi T; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1490-1496. PubMed ID: 29398536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Apixaban Prescribing Patterns for Nonvalvular Atrial Fibrillation in Hospitalized Patients.
    Gibson CM; Smith CB; Davis S; Scalese MJ
    Ann Pharmacother; 2018 Jan; 52(1):54-59. PubMed ID: 28799408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    van den Dries CJ; Pajouheshnia R; van den Ham HA; Souverein P; Moons KGM; Hoes AW; Geersing GJ; van Doorn S
    Br J Clin Pharmacol; 2023 Feb; 89(2):751-761. PubMed ID: 36102068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
    Shen NN; Ferroni E; Amidei CB; Canova C; Peron V; Wang JL; Lin HW; Gu ZC
    Clin Appl Thromb Hemost; 2023; 29():10760296231179439. PubMed ID: 37264798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Off-Label Dosing of Direct Oral Anticoagulants Among Inpatients With Atrial Fibrillation in the United States.
    Sandhu A; Kaltenbach LA; Chiswell K; Shimoga V; Ashur C; Pribish A; Fonarow GC; Piccini JP; Ho PM; Varosy PD; Hess PL
    Circ Cardiovasc Qual Outcomes; 2023 Dec; 16(12):e010062. PubMed ID: 37929603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation　- ANAFIE Registry Sub-Analysis.
    Akao M; Inoue H; Yamashita T; Atarashi H; Ikeda T; Koretsune Y; Okumura K; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Shimizu W
    Circ J; 2023 Nov; 87(12):1765-1774. PubMed ID: 37482411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of Off-Label Underdosing of Direct Oral Anticoagulants After Ablation for Atrial Fibrillation.
    Wakamatsu Y; Nagashima K; Watanabe R; Arai M; Yokoyama K; Matsumoto N; Otsuka T; Suzuki S; Hirata A; Murakami M; Takami M; Kimura M; Fukaya H; Nakahara S; Kato T; Hayashi H; Iwasaki YK; Shimizu W; Nakajima I; Harada T; Koyama J; Okumura K; Tokuda M; Yamane T; Tanimoto K; Momiyama Y; Nonoguchi N; Soejima K; Ejima K; Hagiwara N; Harada M; Sonoda K; Inoue M; Kumagai K; Hayashi H; Yazaki Y; Satomi K; Watari Y; Okumura Y
    Int Heart J; 2020 Nov; 61(6):1165-1173. PubMed ID: 33191353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.